NOAH website
Compendium home page
Introduction
Presentation
Uses
Dosage and administration
Contra-indications, warnings, etc
Pharmaceutical precautions
Legal category
Packaging Quantities
Further information
Marketing authorisation number
Significant Changes
You are here:
Introduction
> Presentation
Ubrolexin Intramammary Suspension for lactating dairy cows: Presentation
Ubrolexin Intramammary Suspension for lactating dairy cows
Presentation
Each intramammary syringe contains:
Cefalexin (as the monohydrate)
200 mg
Kanamycin (as monosulphate)
100,000 I.U.
Date updated: 19 September 2008
Powered by the Librios Semantic Environment